(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.42%.
Scholar Rock Holding's revenue in 2026 is $0.On average, 19 Wall Street analysts forecast SRRK's revenue for 2026 to be $689,182,911, with the lowest SRRK revenue forecast at $233,949,527, and the highest SRRK revenue forecast at $1,342,682,734. On average, 19 Wall Street analysts forecast SRRK's revenue for 2027 to be $18,243,435,244, with the lowest SRRK revenue forecast at $8,951,218,227, and the highest SRRK revenue forecast at $27,171,514,267.
In 2028, SRRK is forecast to generate $45,625,638,048 in revenue, with the lowest revenue forecast at $26,614,955,528 and the highest revenue forecast at $64,564,467,252.